For: | Georgiev T, Angelov AK. Complexities of diagnosis and management of COVID-19 in autoimmune diseases: Potential benefits and detriments of immunosuppression. World J Clin Cases 2020; 8(17): 3669-3678 [PMID: 32953843 DOI: 10.12998/wjcc.v8.i17.3669] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i17/3669.htm |
Number | Citing Articles |
1 |
Snejina Vassileva, Valeria Mateeva, Kossara Drenovska. Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?. Clinics in Dermatology 2021; 39(3): 430 doi: 10.1016/j.clindermatol.2021.01.020
|
2 |
Simona Bogdanova. Musculoskeletal pain in patients with COVID-19. Rheumatology (Bulgaria) 2022; : 3 doi: 10.35465/30.2.2022.pp3-17
|
3 |
Giulia Costanzo, William Cordeddu, Luchino Chessa, Stefano Del Giacco, Davide Firinu. COVID-19: Considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic. World Journal of Clinical Cases 2021; 9(20): 5352-5357 doi: 10.12998/wjcc.v9.i20.5352
|
4 |
Proceedings of the International Conference on Sustainable Innovation on Humanities, Education, and Social Sciences (ICOSI-HESS 2022). 2022; : 309 doi: 10.2991/978-2-494069-65-7_27
|
5 |
Tsvetelina Velikova, Tsvetoslav Georgiev. SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatology International 2021; 41(3): 509 doi: 10.1007/s00296-021-04792-9
|
6 |
Georgi Vasilev, Plamena Kabakchieva, Dimitrina Miteva, Hristiana Batselova, Tsvetelina Velikova. Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World Journal of Diabetes 2022; 13(9): 738-751 doi: 10.4239/wjd.v13.i9.738
|
7 |
Metodija Sekulovski, Simona Bogdanova-Petrova, Monika Peshevska-Sekulovska, Tsvetelina Velikova, Tsvetoslav Georgiev. COVID-19 related liver injuries in pregnancy. World Journal of Clinical Cases 2023; 11(9): 1918-1929 doi: 10.12998/wjcc.v11.i9.1918
|
8 |
Alexia Plocque, Christie Mitri, Charlène Lefèvre, Olivier Tabary, Lhousseine Touqui, Francois Philippart. Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far?. Drugs 2023; 83(1): 1 doi: 10.1007/s40265-022-01803-2
|
9 |
Sehnaz Olgun Yıldızeli, Duygu Vezir, Canan Cimsit, Derya Kocakaya, Zeynep Mercanci, Baran Balcan, Onur Ermerak, Can Ilgin, Emel Eryuksel, Sait Karakurt. Pre-existing Immunocompromised Status as a Preventer of Mortality in COVID-19 Patients: Friend or Foe?. Cureus 2023; doi: 10.7759/cureus.37633
|